Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
Poscher
M
M
University of California San Francisco, Medical Center, San Francisco, CA.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000212:Acyclovir / Q000008:administration & dosage; D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D016049:Didanosine / Q000008:administration & dosage; D017277:Drug Approval; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D019259:Lamivudine; D008329:Managed Care Programs / Q000191:economics / Q000458:organization & administration; D014481:United States; D016047:Zalcitabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015215:Zidovudine / Q000008:administration & dosage
D000998:Antiviral Agents; D004338:Drug Combinations; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine; D000212:Acyclovir